ASRS
MRNA icon

Arizona State Retirement System’s Moderna MRNA Stock Holding History

Arizona State Retirement System’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.49M Sell
92,629
-3,964
-4% -$205K 0.03% 400
2026
Q1 		$4.91M Sell
96,593
-1,349
-1% -$62.9K 0.03% 436
2025
Q4 		$2.89M Sell
97,942
-5,034
-5% -$137K 0.02% 624
2025
Q3 		$2.66M Buy
102,976
+1,465
+1% +$40.9K 0.01% 668
2025
Q2 		$2.8M Buy
101,511
+6,950
+7% +$183K 0.02% 620
2025
Q1 		$2.68M Sell
94,561
-298
-0.3% -$10.6K 0.02% 610
2024
Q4 		$3.94M Buy
94,859
+1,446
+2% +$69.1K 0.02% 505
2024
Q3 		$6.24M Sell
93,413
-936
-1% -$85.9K 0.04% 368
2024
Q2 		$11.2M Buy
94,349
+1,345
+1% +$170K 0.07% 224
2024
Q1 		$9.91M Buy
93,004
+1,988
+2% +$200K 0.07% 260
2023
Q4 		$9.05M Sell
91,016
-701
-0.8% -$59K 0.07% 265
2023
Q3 		$9.47M Sell
91,717
-1,991
-2% -$222K 0.08% 234
2023
Q2 		$11.4M Buy
93,708
+4,544
+5% +$606K 0.09% 201
2023
Q1 		$13.7M Sell
89,164
-1,439
-2% -$237K 0.12% 149
2022
Q4 		$16.3M Sell
90,603
-1,300
-1% -$213K 0.16% 122
2022
Q3 		$10.9M Sell
91,903
-2,045
-2% -$310K 0.11% 165
2022
Q2 		$13.4M Sell
93,948
-619
-0.7% -$88.5K 0.13% 143
2022
Q1 		$16.3M Buy
94,567
+598
+0.6% +$101K 0.13% 140
2021
Q4 		$23.9M Sell
93,969
-1,206
-1% -$353K 0.18% 101
2021
Q3 		$36.6M Buy
95,175
+6,480
+7% +$2.39M 0.3% 60
2021
Q2 		$20.8M Buy
88,695
+10,636
+14% +$1.9M 0.17% 110
2021
Q1 		$10.2M Sell
78,059
-1,145
-1% -$166K 0.09% 209
2020
Q4 		$8.27M Sell
79,204
-3,614
-4% -$366K 0.08% 251
2020
Q3 		$5.86M Buy
82,818
+19,418
+31% +$1.35M 0.06% 296
2020
Q2 		$4.07M Buy
+63,400
New +$3.47M 0.06% 305

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Arizona State Retirement System's MRNA Position: Q2 2026 in Review

Arizona State Retirement System reduced its Moderna (MRNA) stake by 4.1% in Q2 2026, selling an estimated $205K and leaving 92,629 shares worth $6.49M. The position accounts for 0.03% of the portfolio, ranked #400.

Arizona State Retirement System first reported a position in MRNA in Q2 2020 and has held it in 25 quarters since. The position peaked at $36.6M in Q3 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Arizona State Retirement System held 92,629 shares of Moderna worth $6.49M as of Q2 2026.
  • Arizona State Retirement System sold 3,964 Moderna shares in Q2 2026, an estimated $205K.
  • Moderna made up 0.03% of Arizona State Retirement System's portfolio in Q2 2026, its #400 holding.
  • Arizona State Retirement System first reported a position in Moderna in Q2 2020 and has held it in 25 quarters since.
  • Arizona State Retirement System's Moderna position peaked at $36.6M in Q3 2021.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.